PASSPORT baseline demographics#
| Subjects n | 530 |
| Age years | 69.4±8.8 |
| Males | 427 (80.6) |
| White | 400/404 (99.0) |
| FVC % predicted¶ | 64.5±16.6 |
| Supplemental O2 use | 157/527 (29.8) |
| Time since IPF diagnosis years+ | 1.8±3.5 |
| IFP diagnosis | |
| High-resolution computed tomography | 423 (79.8) |
| Surgical lung biopsy | 150 (28.3) |
| Smoking status n | 526 |
| Current | 14 (2.7) |
| Former | 312 (59.3) |
| Never | 200 (38.0) |
Data are presented as mean±SD, n (%) or n/N (%), unless otherwise stated. PASSPORT: Pirfenidone Post-Authorisation Safety Registry; FVC: forced vital capacity; IPF: idiopathic pulmonary fibrosis. #: interim analysis, December 2013; ¶: n=384; +: n=527. Data from [12].